Meet the media team
Find a media contact in your region
Learn more
Total 215 Results for:
Showing 24 out of 215 results
27 5月 2026
Herbert Smith Freehills Kramer advises PBF Energy in $500 million offering of senior notes
Leading global law firm Herbert Smith Freehills Kramer has advised Campbell Lutyens on its acquisition by Lazard, Inc. for $575 million, with up to a …
20 5月 2026
Herbert Smith Freehills Kramer advises the sole sponsor on UISEE Technologies’ Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised CITIC Securities (Hong Kong) Limited as the sole sponsor on UISEE Technologies …
28 4月 2026
Herbert Smith Freehills Kramer advises joint sponsors on Mabwell’s Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised CITIC Securities (Hong Kong) Limited and Haitong International Capital Limited as …
15 4月 2026
Backlog of IPOs to flow through in second half of 2026: HSF Kramer report
With geopolitical uncertainty curtailing the number of early IPOs markets were expecting at the start of the year, a new report from HSF Kramer predicts …
15 4月 2026
Herbert Smith Freehills Kramer advises Telix Pharmaceuticals Limited on its US$600 million offer of convertible bonds and concurrent repurchase of existing convertible bonds
HSF Kramer is pleased to have advised Telix Pharmaceuticals Limited on the offering of US$600 million of new convertible bonds due 2031, which bonds will …
13 4月 2026
Herbert Smith Freehills Kramer strengthens Hong Kong capital markets team with Of Counsel hire
Leading global law firm Herbert Smith Freehills Kramer has appointed Scarlet Feng as Of Counsel in Hong Kong, further strengthening its China‑related …
19 3月 2026
Herbert Smith Freehills Kramer advises on VOYAH's Hong Kong listing and Dongfeng Motor Group privatisation
Leading global law firm Herbert Smith Freehills Kramer has advised on the listing of VOYAH Automotive Technology Co., Ltd. (07489.HK) on the Main Board …
13 2月 2026
Herbert Smith Freehills Kramer advises PYC Therapeutics Limited on ~A$653 million capital raise
HSF Kramer is proud to have advised PYC Therapeutics Limited on its current capital raising to raise up to approximately A$653 million, comprising a …
3 2月 2026
Herbert Smith Freehills Kramer advises Aura Consolidated Group, Inc. on transformational combination with Qoria Limited and ASX listing
HSF Kramer is pleased to be advising Boston-based Aura Consolidated Group, Inc. on its combination with Qoria Limited and Aura’s concurrent listing on …
3 2月 2026
Herbert Smith Freehills Kramer advises Eastroc Beverage on its over HK$10 billion Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised Eastroc Beverage (Group) Co. Ltd. (09980.HK, 605499.SS) on its listing on the Main …
22 1月 2026
Herbert Smith Freehills Kramer advises underwriters on Longcheer Technology's Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised Citigroup Global Markets Asia Limited, Haitong International Capital Limited, Haitong …
22 1月 2026
Herbert Smith Freehills Kramer advises 29Metals on A$150 million capital raise
HSF Kramer is pleased to have advised 29Metals on the successful launch of a $150 million capital raise, conducted by way of a fully underwritten, …
Showing 24 out of 215 results
View moreCode≠Law: In a race between innovation and oversight, which one sets the pace?
The second chapter of our series explores the forces shaping AI’s next phase and what they mean for business
Read our latest report